(603590)"Beijing Konruns Pharmaceutical Co., Ltd."Announcement on Progress in Repurchasing Shares
Filed with SSE · Stock code 603590 · · 2 pages · Chinese
Summary by 6ix AI
Beijing Konruns Pharmaceutical Co., Ltd. has announced progress on its share repurchase plan, detailing the number of shares repurchased and the total amount spent as of a specific date.
Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries
Beijing Konruns Pharmaceutical Co., Ltd. on 6ix
Story so far
Earlier from Beijing Konruns Pharmaceutical
- Announcement on Convening the 2026 Semi-annual Performance Briefing
- Announcement on the Arbitration Result
- Announcement on Results of the Initial Grant under the 2026 Restricted Share Incentive Plan
- Announcement on Obtaining New Veterinary Drug Registration Certificate
- Announcement on Release of Trading Restrictions and Listing of Shares for the 3rd Lock-up Period of the Initial Grant under the 2023 Restricted Share Incentive Plan
Later from Beijing Konruns Pharmaceutical
- (603590)"Beijing Konruns Pharmaceutical Co., Ltd."Announcement on Change of Registered Capital and Amendment to the Articles of Association
- (603590)"Beijing Konruns Pharmaceutical Co., Ltd."Announcement on Repurchase and Cancellation of Restricted Shares Granted to Certain Incentive Participants but Not Yet Released from Trading Restrictions
- (603590)"Beijing Konruns Pharmaceutical Co., Ltd."Announcement on Resolutions of the 7th Meeting of the 5th Board of Directors
- (603590)"Beijing Konruns Pharmaceutical Co., Ltd."Notice on Convening the 2nd Extraordinary General Meeting in 2026
- (603590)"Beijing Konruns Pharmaceutical Co., Ltd."Announcement on Implementation Results of Share Repurchase and Share Changes
Follow Beijing Konruns Pharmaceutical into a list and get an email when it puts out news.
Follow Beijing Konruns Pharmaceutical